Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients

1. Ribelles, N.
2. Jerez, J.M.
3. Rodriguez-Brazzarola, P.
4. Jimenez, B.
5. Diaz-Redondo, T.
6. Mesa, H.
7. Marquez, A.
8. Sanchez-Muñoz, A.
9. Pajares, B.
10. Carabantes, F.
11. Bermejo, M.J.
12. Villar, E.
13. Dominguez-Recio, M.E.
14. Saez, E.
15. Galvez, L.
16. Godoy, A.
17. Franco, L.
18. Ruiz-Medina, S.
19. Lopez, I.
20. Alba, E.